mSphere
(Jun 2021)
Effect of Subcutaneous Anti-CD20 Antibody-Mediated B Cell Depletion on Susceptibility to Pneumocystis Infection in Mice
- Guixiang Dai,
- Kristin Noell,
- Gisbert Weckbecker,
- Jay K. Kolls
Affiliations
- Guixiang Dai
- Center for Translational Research in Infection and Inflammation, Tulane University School of Medicine, New Orleans, Louisiana, USA
- Kristin Noell
- Center for Translational Research in Infection and Inflammation, Tulane University School of Medicine, New Orleans, Louisiana, USA
- Gisbert Weckbecker
- Novartis, Basel, Switzerland
- Jay K. Kolls
- ORCiD
- Center for Translational Research in Infection and Inflammation, Tulane University School of Medicine, New Orleans, Louisiana, USA
- DOI
-
https://doi.org/10.1128/mSphere.01144-20
- Journal volume & issue
-
Vol. 6,
no. 3
Abstract
Read online
Anti-CD20 antibody therapy is used for both cancer and autoimmune disease but has been shown to be associated with PneumocystisPneumocystis
WeChat QR code
